Dataset Information

A hybrid data envelopment analysis-artificial neural network prediction model for COVID-19 severity in transplant recipients.

ABSTRACT: In an overwhelming demand scenario, such as the SARS-CoV-2 pandemic, pressure over health systems may outburst their predicted capacity to deal with such extreme situations. Therefore, in order to successfully face a health emergency, scientific evidence and validated models are needed to provide real-time information that could be applied by any health center, especially for high-risk populations, such as transplant recipients. We have developed a hybrid prediction model whose accuracy relative to several alternative configurations has been validated through a battery of clustering techniques. Using hospital admission data from a cohort of hospitalized transplant patients, our hybrid Data Envelopment Analysis (DEA)-Artificial Neural Network (ANN) model extrapolates the progression towards severe COVID-19 disease with an accuracy of 96.3%, outperforming any competing model, such as logistic regression (65.5%) and random forest (44.8%). In this regard, DEA-ANN allows us to categorize the evolution of patients through the values of the analyses performed at hospital admission. Our prediction model may help guiding COVID-19 management through the identification of key predictors that permit a sustainable management of resources in a patient-centered model.

Supplementary information

The online version contains supplementary material available at 10.1007/s10462-021-10008-0.

SUBMITTER: Revuelta I

PROVIDER: S-EPMC8062617 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A hybrid data envelopment analysis-artificial neural network prediction model for COVID-19 severity in transplant recipients.

Revuelta Ignacio I Santos-Arteaga Francisco J FJ Montagud-Marrahi Enrique E Ventura-Aguiar Pedro P Di Caprio Debora D Cofan Frederic F Cucchiari David D Torregrosa Vicens V Piñeiro Gaston Julio GJ Esforzado Nuria N Bodro Marta M Ugalde-Altamirano Jessica J Moreno Asuncion A Campistol Josep M JM Alcaraz Antonio A Bayès Beatriu B Poch Esteban E Oppenheimer Federico F Diekmann Fritz F

Artificial intelligence review 20210423 6

In an overwhelming demand scenario, such as the SARS-CoV-2 pandemic, pressure over health systems may outburst their predicted capacity to deal with such extreme situations. Therefore, in order to successfully face a health emergency, scientific evidence and validated models are needed to provide real-time information that could be applied by any health center, especially for high-risk populations, such as transplant recipients. We have developed a hybrid prediction model whose accuracy relative ...[more]

PMID: 33907345

Similar Datasets

Project description:BackgroundStratification of patient subpopulations that respond favorably to treatment or experience and adverse reaction is an essential step toward development of new personalized therapies and diagnostics. It is currently feasible to generate omic-scale biological measurements for all patients in a study, providing an opportunity for machine learning models to identify molecular markers for disease diagnosis and progression. However, the high variability of genetic background in human populations hampers the reproducibility of omic-scale markers. In this paper, we develop a biological network-based regularized artificial neural network model for prediction of phenotype from transcriptomic measurements in clinical trials. To improve model sparsity and the overall reproducibility of the model, we incorporate regularization for simultaneous shrinkage of gene sets based on active upstream regulatory mechanisms into the model.ResultsWe benchmark our method against various regression, support vector machines and artificial neural network models and demonstrate the ability of our method in predicting the clinical outcomes using clinical trial data on acute rejection in kidney transplantation and response to Infliximab in ulcerative colitis. We show that integration of prior biological knowledge into the classification as developed in this paper, significantly improves the robustness and generalizability of predictions to independent datasets. We provide a Java code of our algorithm along with a parsed version of the STRING DB database.ConclusionIn summary, we present a method for prediction of clinical phenotypes using baseline genome-wide expression data that makes use of prior biological knowledge on gene-regulatory interactions in order to increase robustness and reproducibility of omic-scale markers. The integrated group-wise regularization methods increases the interpretability of biological signatures and gives stable performance estimates across independent test sets.

Dataset Information

A hybrid data envelopment analysis-artificial neural network prediction model for COVID-19 severity in transplant recipients.

Supplementary information

Publications

A hybrid data envelopment analysis-artificial neural network prediction model for COVID-19 severity in transplant recipients.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets